-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
A re-engineered immunotoxin shows promising preclinical activity in ovarian cancer
Veröffentlicht in Scientific reports
VolltextArtikel -
11
-
12
-
13